Aura Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Elisabet de los Pinos, with a market cap of $786.8M.
Based on Q1 2026 filing
Common questions about Aura Biosciences, Inc.
Aura Biosciences, Inc. (AURA) has a market capitalization of $786.8M and trades on NASDAQ.
Aura Biosciences, Inc. has approximately 89 employees.